Notice Number: NOT-OD-19-027
Release Date: November 5, 2018
Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)
Frequently Asked Questions (FAQs)
On September 21, 2018, the NIH Office of Disease Prevention issued the Funding Opportunity Announcement (FOA) PA-18-932 "Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)." To assist prospective applicants with the above-referenced FOA, the NIH developed a list of Frequently Asked Questions (FAQs) to address common inquiries. The FAQs document for this FOA is posted at: https://prevention.nih.gov/sites/default/files/2018-10/PA_18_932_FAQs_Final.pdf. The FAQs may be updated without additional notice. In addition to the FAQs, NIH staff will also respond to questions submitted by potential applicants to the Agency Contacts listed in the FOA.
An informational webinar will be held on December 4, 2018, from 1:00pm to 2:00pm (Eastern Time) for all prospective applicants interested in PA-18-932 "Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)." During the webinar, staff from the NIH will provide an overview of the FOA and answer questions from prospective applicants. Participation in the webinar is not a prerequisite to applying. All interested individuals will need to register in advance to participate in the webinar. Registration information can be accessed at: Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations PA Webinar Registration. A closed-captioned copy of the webinar will be posted online approximately one week after the event at: https://prevention.nih.gov/funding/funding-opportunities/webinar-increasing-uptake-evidence-based-screening-diverse-adult-populations-r01. Applicant questions will be accepted during the webinar via WebEx. While an effort will be made to include all questions in the webinar, it is possible that not all questions will be addressed during the event due to time constraints.
Please direct all inquiries to:
Dionne C. Godette, PhD
Office of Disease Prevention (ODP)